WPD Pharmaceuticals (HAM:8SV) EV-to-EBIT : -7.00 (As of May. 28, 2025)

WPD Pharmaceuticals EV-to-EBIT Chart

WPD Pharmaceuticals Annual Data
	Trend	Jan13	Jan14	Jan15	Jan16	Jan17	Jan18	Jan19	Dec20	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					-22.83	-13.25	-	1.26	-

WPD Pharmaceuticals Quarterly Data
	Jul19	Oct19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-EBIT	Get a 7-Day Free Trial															0.87	-	-19.07	-9.67	-11.88

Competitive Comparison of WPD Pharmaceuticals's EV-to-EBIT

For the Biotechnology subindustry, WPD Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WPD Pharmaceuticals's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WPD Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where WPD Pharmaceuticals's EV-to-EBIT falls into.

WPD Pharmaceuticals EV-to-EBIT Calculation

WPD Pharmaceuticals's EV-to-EBIT for today is calculated as:

WPD Pharmaceuticals's current Enterprise Value is €0.39 Mil.
WPD Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WPD Pharmaceuticals  (HAM:8SV) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

WPD Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

WPD Pharmaceuticals's Enterprise Value for the quarter that ended in Sep. 2024 was €0.95 Mil.
WPD Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WPD Pharmaceuticals EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

WPD Pharmaceuticals Business Description